FdaApplication
ANDA 212692
Identifiers
- fda_app_no: ANDA212692
Properties
| Property | Value |
|---|---|
| applicant_name | EXELA PHARMA SCIENCES LLC |
| application_type | ANDA |
| approval_date | 2021-10-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POTASSIUM ACETATE | POTASSIUM ACETATE | 2MEQ/ML | INJECTABLE;INJECTION |
1 product